Nattokinase
- Generic Name
- Nattokinase
- Drug Type
- Biotech
- CAS Number
- 133876-92-3
- Unique Ingredient Identifier
- H81695M5OP
Overview
Nattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).
Background
Nattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
St. Paul Brands Verestor
Manufacturer:Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals
Route:ORAL
Strength:100 mg in 1 1
Approved: 2025/03/31
NDC:13411-861
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath